Combining MRI and clinical tests to predict outcomes in multiple myeloma treatment
A framework for integrating MR imaging and clinical tests for prediction of outcomes in multiple myeloma treatment
This study is looking to help people with multiple myeloma by using MRI scans along with lab test results to better predict how well different treatments will work for them, so they can receive more personalized care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10991020 on NIH RePORTER |
What this research studies
This research aims to improve the prediction of treatment outcomes for patients with multiple myeloma by integrating MRI imaging with clinical test results. By analyzing the tumor's evolution through non-invasive MRI and various laboratory values, the study seeks to create a more accurate model for assessing patient prognosis. This approach could lead to personalized treatment plans that are better suited to individual patient needs, ultimately enhancing the management of this complex disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with multiple myeloma who are undergoing treatment and have varying prognoses.
Not a fit: Patients with other types of hematologic malignancies or those not receiving treatment for multiple myeloma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate predictions of treatment outcomes, allowing for tailored therapies that improve patient survival and quality of life.
How similar studies have performed: Previous research has shown promise in using imaging techniques alongside clinical data to enhance treatment predictions, indicating that this approach has potential for success.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Zhou, Chuan — University of Michigan at Ann Arbor
- Study coordinator: Zhou, Chuan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.